SCHEMBL952622

SCHEMBL952622

O=C(O)Cc1c[nH]nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9568028 0.84
SCHEMBL12050684 0.83 KDM4E (0.35)
SCHEMBL9070532 0.83
Hydrochloric Acid SCHEMBL28028538 0.79
SCHEMBL1310865 0.79 KEAP1 (0.38)
SCHEMBL4890544 0.78
SCHEMBL9196900 0.78 TDP1 (0.33)
SCHEMBL1966242 0.76 MAPK1 (0.31)
SCHEMBL28633894 0.76 KDM6B (0.47)
SCHEMBL8491984 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109438374-B Continuous synthesis method of rufinamide 凯莱英医药集团(天津)股份有限公司 2020-10-30 CN claimed
CN-109384770-B N-substituted triazole acetyl tert-butyl dihydroquinoxaline derivatives, synthesis method and application thereof as bactericide 三峡大学 2020-10-30 CN claimed
CN-109400588-B Fluorine-containing triazole quinoxaline bactericide, preparation method and application thereof 湖北文理学院 2020-09-25 CN claimed
US-20110003807-A1 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US claimed
US-20110003806-A1 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US claimed
EP-0531382-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-03-17 EP claimed
EP-0047560-B1 PROCESS FOR THE PREPARATION OF 7-ACYLAMINO-3-(THIO-SUBSTITUTED)METHYL-3-CEPHEM-4-CARBOXYLIC ACID 1-OXIDE DERIVATIVES GIST-BROCADES N.V. (NL) 1985-04-10 EP claimed
CN-115210411-B Filled microstructure and method of transporting the same 富士胶片株式会社 2025-04-01 CN disclosed
US-12233132-B2 Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same SERINA THERAPEUTICS, INC. (US) 2025-02-25 US disclosed
US-12227863-B2 Anodizing method and manufacturing method for an anisotropic conductive member FUJIFILM CORPORATION (JP) 2025-02-18 US disclosed
US-12147158-B2 Photocurable composition and method for producing semiconductor device NISSAN CHEMICAL CORPORATION (JP) 2024-11-19 US disclosed
WO-2024203030-A1 JOINED BODY MANUFACTURING METHOD AND STRUCTURE SET 富士フイルム株式会社 2024-10-03 WO disclosed
CN-118638140-A Oxo-substituted compounds 住友制药株式会社 2024-09-13 CN disclosed
EP-1089964-A1 HYDRAZINE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2001-04-11 EP disclosed
WO-2000000465-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-01-06 WO disclosed
EP-0531382-A1 N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-03-17 EP disclosed
US-5075488-A Fungicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-12-24 US disclosed
EP-0128006-B1 A SOIL-DISEASE-CONTROLLING AGENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-09-18 EP disclosed
US-4709052-A FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-11-24 US disclosed
EP-0128006-A2 A soil-disease-controlling agent SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-12-12 EP disclosed